Related Experiment Video
Updated: May 5, 2026

11:27
Quantitative Multispectral Analysis Following Fluorescent Tissue Transplant for Visualization of Cell Origins, Types, and Interactions
Published on: September 22, 2013
9.5K
Comparing Xenium 5K and Visium HD data from identical tissue slide at a pathological perspective.
Mengping Long1, Taobo Hu1, Weixin Wang2
1Science for Life Laboratory, Department of Biochemistry and Biophysics, Stockholm University, Stockholm, Sweden.
Journal of Experimental & Clinical Cancer Research : CR
|July 27, 2025
Summary
Comparing Visium-HD and Xenium in-situ spatial transcriptomics technologies reveals distinct strengths. Visium-HD offers broad gene coverage, while Xenium excels in single-cell resolution, with pathological context guiding technology selection.
Area of Science:
- Spatial transcriptomics
- Molecular pathology
- High-resolution imaging
Background:
- Visium-HD (sequencing-based) offers 2µm resolution and whole-transcriptome coverage.
- Xenium in-situ (imaging-based) provides sub-micron resolution for targeted gene detection.
- Both technologies were applied to identical lung tissue slides for direct comparison.
Discussion:
- Visium-HD provides broader gene detection and may identify more tumor subclones.
- Xenium-5K achieves comparable results with advanced clustering algorithms.
- Xenium's single-cell segmentation is advantageous for irregular cell shapes.
Key Insights:
- Xenium's reliance on fluorescent signals poses challenges in pigmented tissues (e.g., melanoma, macrophages).
- Visium-HD may be superior for applications involving heavily pigmented tissues.
- Pathological considerations are crucial for selecting the optimal spatial transcriptomics approach.
Outlook:
- Further validation of Xenium's performance with robust clustering is warranted.
- Investigating Visium-HD's utility in challenging pigmented tissue environments is important.
- Tailoring spatial transcriptomics technology choice to specific research questions and tissue types is essential for advancing cancer research.

